These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8595168)

  • 1. Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice.
    Webster LK; Cosson EJ; Stokes KH; Millward MJ
    Br J Cancer; 1996 Feb; 73(4):522-4. PubMed ID: 8595168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of cremophor EL with bolus doxorubicin.
    Millward MJ; Webster LK; Rischin D; Stokes KH; Toner GC; Bishop JF; Olver IN; Linahan BM; Linsenmeyer ME; Woodcock DM
    Clin Cancer Res; 1998 Oct; 4(10):2321-9. PubMed ID: 9796961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.
    Sparreboom A; van Tellingen O; Nooijen WJ; Beijnen JH
    Cancer Res; 1996 May; 56(9):2112-5. PubMed ID: 8616858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
    Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
    Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.
    Danesi R; Innocenti F; Fogli S; Gennari A; Baldini E; Di Paolo A; Salvadori B; Bocci G; Conte PF; Del Tacca M
    Br J Clin Pharmacol; 2002 May; 53(5):508-18. PubMed ID: 11994057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicokinetics of the active doxorubicin metabolite, doxorubicinol, in sulphur-crested cockatoos (Cacatua galerita).
    Gilbert CM; Filippich LJ; McGeary RP; Charles BG
    Res Vet Sci; 2007 Aug; 83(1):123-9. PubMed ID: 17197005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of paclitaxel elimination in the isolated perfused rat liver by Cremophor EL.
    Ellis AG; Webster LK
    Cancer Chemother Pharmacol; 1999; 43(1):13-8. PubMed ID: 9923536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of paclitaxel and Cremophor EL on mast cell histamine secretion and their interaction with adriamycin.
    Decorti G; Bartoli Klugmann F; Candussio L; Baldini L
    Anticancer Res; 1996; 16(1):317-20. PubMed ID: 8615628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit.
    Cusack BJ; Tesnohlidek DA; Loseke VL; Vestal RE; Brenner DE; Olson RD
    Cancer Chemother Pharmacol; 1988; 22(4):294-8. PubMed ID: 3168142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin pharmacokinetics following a single-dose infusion to sulphur-crested cockatoos (Cacatua galerita).
    Gilbert CM; Filippich LJ; Charles BG
    Aust Vet J; 2004 Dec; 82(12):769-72. PubMed ID: 15648940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profiles of doxorubicin in combination with taxanes.
    Holmes FA; Rowinsky EK
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):8-14. PubMed ID: 11552225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
    Booth CL; Brouwer KR; Brouwer KL
    Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel induces significant changes in epidoxorubicin distribution in mice.
    Colombo T; Gonzalez Paz O; Zucchetti M; Maneo A; Sessa C; Goldhirsch A; D'Incalci M
    Ann Oncol; 1996 Oct; 7(8):801-5. PubMed ID: 8922193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.
    Gianni L; Viganò L; Locatelli A; Capri G; Giani A; Tarenzi E; Bonadonna G
    J Clin Oncol; 1997 May; 15(5):1906-15. PubMed ID: 9164201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry.
    Dobbs NA; Twelves CJ; Gillies H; James CA; Harper PG; Rubens RD
    Cancer Chemother Pharmacol; 1995; 36(6):473-6. PubMed ID: 7554038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma.
    Pérez-Blanco JS; Santos-Buelga D; Fernández de Gatta MD; Hernández-Rivas JM; Martín A; García MJ
    Br J Clin Pharmacol; 2016 Dec; 82(6):1517-1527. PubMed ID: 27447545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: implications for cardiotoxicity of doxorubicin-taxane chemotherapies.
    Salvatorelli E; Menna P; Cascegna S; Liberi G; Calafiore AM; Gianni L; Minotti G
    J Pharmacol Exp Ther; 2006 Jul; 318(1):424-33. PubMed ID: 16614166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices: Application to a pharmaco-delivery study.
    Mazzucchelli S; Ravelli A; Gigli F; Minoli M; Corsi F; Ciuffreda P; Ottria R
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27714830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80.
    Ellis AG; Crinis NA; Webster LK
    Cancer Chemother Pharmacol; 1996; 38(1):81-7. PubMed ID: 8603456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Determination of Doxorubicin and its Metabolites Doxorubicinol, Doxorubicinone, Doxorubicinolone, and 7-Deoxydoxorubicinone in Mouse Plasma.
    Choi WG; Kim DK; Shin Y; Park R; Cho YY; Lee JY; Kang HC; Lee HS
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32164308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.